We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+16.98%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$295B
AUM Growth
+$35.4B
(+14%)
Cap. Flow
-$1.58B
Cap. Flow
% of AUM
-0.53%
Top 10 Holdings %
Top 10 Hldgs %
22.42%
Holding
3,425
New
145
Increased
1,798
Reduced
1,253
Closed
125
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1B |
| 2 |
Apple
AAPL
|
+$797M |
| 3 |
Merck
MRK
|
+$316M |
| 4 |
Amazon
AMZN
|
+$308M |
| 5 |
Medtronic
MDT
|
+$298M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$587M |
| 2 |
NXP Semiconductors
NXPI
|
+$554M |
| 3 |
Meta Platforms (Facebook)
META
|
+$449M |
| 4 |
Intuit
INTU
|
+$433M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.73% |
| 2 | Healthcare | 13.29% |
| 3 | Consumer Discretionary | 13.23% |
| 4 | Financials | 12.2% |
| 5 | Communication Services | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
X4 Pharmaceuticals
XFOR
$460M
| $541K | ﹤0.01% |
2,808
+38
| +1% | +$7.46K |
|
|
IVAC
3002
DELISTED
Intevac Inc
IVAC
| $540K | ﹤0.01% |
74,892
+17,022
| +29% | +$102K |
|
3003
iRadimed
IRMD
$1.18B
| $536K | ﹤0.01% |
23,526
+551
| +2% | +$12.7K |
|
|
LX
3004
LexinFintech Holdings
LX
$241M
| $531K | ﹤0.01% |
+79,200
| New | +$566K |
|
3005
Pampa Energía
PAM
$4.41B
| $529K | ﹤0.01% |
38,383
-10,100
| -21% | -$130K |
|
3006
Gaia
GAIA
$48.4M
| $525K | ﹤0.01% |
53,117
+707
| +1% | +$7.4K |
|
3007
Pliant Therapeutics
PLRX
$65M
| $525K | ﹤0.01% |
23,105
| – | – |
|
3008
Tiptree Inc
TIPT
$675M
| $525K | ﹤0.01% |
104,500
+12,885
| +14% | +$66.8K |
|
3009
Information Services Group
III
$251M
| $522K | ﹤0.01% |
159,036
+2,034
| +1% | +$5.31K |
|
|
SMED
3010
DELISTED
Sharps Compliance Corp
SMED
| $522K | ﹤0.01% |
55,220
+8,407
| +18% | +$64.3K |
|
3011
Stratus Properties
STRS
$154M
| $521K | ﹤0.01% |
20,429
+122
| +0.6% | +$2.92K |
|
3012
Arq
ARQ
$89.3M
| $518K | ﹤0.01% |
94,139
+540
| +0.6% | +$2.75K |
|
3013
Chemung Financial Corp
CHMG
$392M
| $512K | ﹤0.01% |
15,056
+5,331
| +55% | +$183K |
|
|
SREV
3014
DELISTED
ServiceSource International, Inc.
SREV
| $512K | ﹤0.01% |
290,980
+74,350
| +34% | +$110K |
|
3015
Eastern Company
EML
$150M
| $508K | ﹤0.01% |
21,047
+9,365
| +80% | +$211K |
|
3016
Genie Energy
GNE
$383M
| $507K | ﹤0.01% |
70,374
+1,631
| +2% | +$13.8K |
|
3017
Gyre Therapeutics
GYRE
$744M
| $505K | ﹤0.01% |
10,686
+407
| +4% | +$17.6K |
|
3018
ADMA Biologics
ADMA
$2.22B
| $501K | ﹤0.01% |
256,937
+1,407
| +0.6% | +$2.96K |
|
3019
IBEX
IBEX
$499M
| $501K | ﹤0.01% |
+26,789
| New | +$477K |
|
|
MPX
3020
DELISTED
Marine Products Corp
MPX
| $498K | ﹤0.01% |
34,268
+245
| +0.7% | +$4.04K |
|
3021
Abeona Therapeutics
ABEO
$413M
| $496K | ﹤0.01% |
12,644
+112
| +0.9% | +$3.81K |
|
3022
Dyne Therapeutics
DYN
$4.9B
| $490K | ﹤0.01% |
+23,318
| New | +$461K |
|
|
PTVCB
3023
DELISTED
Protective Insurance Corporation Class B Common Stock
PTVCB
| $488K | ﹤0.01% |
35,552
+528
| +2% | +$7.44K |
|
3024
Riverview Bancorp
RVSB
$108M
| $486K | ﹤0.01% |
92,369
+19,431
| +27% | +$100K |
|
|
CLPR
3025
Clipper Realty
CLPR
$46.2M
| $476K | ﹤0.01% |
67,497
+12,323
| +22% | +$76.4K |
|
Similar funds
VFT
Nuveen's Q4 2020 Portfolio in Review
As of Q4 2020, Nuveen held 3,425 positions worth $295B, up 14% from $260B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Nuveen's Q4 2020 filing shows 145 new, 1,798 increased, 1,253 reduced and 125 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M. The largest sale was Walt Disney, an estimated $587M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Nuveen's largest Q4 2020 buy was iShares Core MSCI EAFE ETF: 3,133,484 shares worth $216M.
- Nuveen added most to Microsoft in Q4 2020, an estimated $1B increase.
- Nuveen's biggest Q4 2020 reduction was Walt Disney, cutting an estimated $587M.
- Nuveen fully exited Alcon in Q4 2020, selling an estimated $174M.
- Nuveen's ten largest holdings make up 22% of its $295B portfolio in Q4 2020.
- Nuveen opened 145 new positions and closed 125 in Q4 2020.
- Nuveen's portfolio value rose 14% quarter-over-quarter to $295B.
Based on Nuveen's 13F filing for Q4 2020, filed 16 Feb 2021.